By employing CRISPR-mediated genome editing, the team successfully targeted Trp53 and KRas genes, effectively recreating the classic murine non-small cell lung cancer (NSCLC) model Trp53fl/fl:lsl-KRasG12D/wt. This evidence concerns the gene KRAS and non-small cell lung carcinoma.